These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3830770)
1. [Therapeutic effectiveness of PTT-119 evaluated in vivo in experimental models]. Bianchi R; Nardelli B; Allegrucci M; Fioretti MC G Ital Chemioter; 1985; 32(1):1-6. PubMed ID: 3830770 [No Abstract] [Full Text] [Related]
2. [The synthesis and carcinostatic effect of 4-[bis-(2-chloroethyl)-amino]-2, 3-dimethyl-1-phenyl-5-pyrazolone ("imet 3995")]. Werner W; Jungstand W; Gutsche W; Wohlrabe K Pharmazie; 1975 Jul; 30(7):433-5. PubMed ID: 1178756 [No Abstract] [Full Text] [Related]
4. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y. Bohunickå E; Koza I; Ujhåzy V Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976 [No Abstract] [Full Text] [Related]
5. [Change in the antioxidative activity of lipids during treatment of transplantable leukemia with alkylating agents]. Pal'mina NP; Burlakova EB Biofizika; 1973; 18(1):166-9. PubMed ID: 4693538 [No Abstract] [Full Text] [Related]
6. A mouse ependymoblastoma as an experimental model for screening potential antineoplastic drugs. Geran RI; Congleton GF; Dudeck LE; Abbott BJ; Gargus JL Cancer Chemother Rep 2; 1974 Dec; 4(4):53-87. PubMed ID: 4447935 [No Abstract] [Full Text] [Related]
7. [Animal experimental examination of a phase III study on the effect of the combination therapy of bruneomycin, cytostasan and prednisone]. Nowak C; Arnold W; Henneberger G; Tanneberger S Arch Geschwulstforsch; 1983; 53(1):37-44. PubMed ID: 6344835 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in mice. Bhattacharya S; Ganguly C; Sanyal U; Das S Neoplasma; 1994; 41(1):35-8. PubMed ID: 8202193 [TBL] [Abstract][Full Text] [Related]
9. [Cytostatic effect of vinylogous nitrogen mustard carbonamidium salts against transplanted tumors in an automatic preliminary test and a sequential test program]. Gutsche W; Jungstand W; Wohlrabe K; Fischer GW; Lohs K Arch Geschwulstforsch; 1972; 39(2):121-7. PubMed ID: 5065117 [No Abstract] [Full Text] [Related]
10. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan]. Mal'tseva LF Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367 [No Abstract] [Full Text] [Related]
11. [Action of nitrosoalkylureas and the longevity of tumor-bearing animals]. Krutova TV; Kondradov AA; Ostrovskaia LA Izv Akad Nauk SSSR Biol; 1983; (6):843-50. PubMed ID: 6655115 [No Abstract] [Full Text] [Related]
12. [Experimental study of the antitumor properties and mechanism of action of kortifen]. Lagova ND; Kiselev VI; Kurdiumova KN; Sof'ina ZP; Shkodinskaia EN Vopr Onkol; 1989; 35(4):450-6. PubMed ID: 2728387 [TBL] [Abstract][Full Text] [Related]
14. [Action of a synthetic peptide on some syngeneic tumors]. Pugliese A; Negro Ponzi A G Batteriol Virol Immunol; 1975; 68(7-12):231-9. PubMed ID: 1234591 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, acute toxicity and chemotherapeutic anti-cancer activities of a new tripeptidic mustard. De Barbieri A; Dall'Asta L; Comini A; Springolo V; Mosconi P; Coppi G Farmaco Sci; 1983 Apr; 38(4):205-18. PubMed ID: 6861998 [TBL] [Abstract][Full Text] [Related]
16. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products. Marsh JC; Shoemaker RH; Suffness M Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772 [TBL] [Abstract][Full Text] [Related]
17. [Comparative characteristics of the toxicity and antitumor activity of a number of haloid derivatives of embikhin and Nor HN2]. Demirchoglian IG; Babasian OV; Galstian DA Zh Eksp Klin Med; 1979; 19(5):46-52. PubMed ID: 525103 [No Abstract] [Full Text] [Related]
18. [Comparison of biological activity of C- and N-Mannich bases, with and without nitrogen-mustard groups, in microbiological and animal-experiment screening systems in the search of new antineoplastic agents]. Fleck W; Werner W Z Allg Mikrobiol; 1974; 14(7):559-74. PubMed ID: 4219246 [No Abstract] [Full Text] [Related]
19. Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies. Tura S; Mazza P; Gherlinzoni F; Zinzani PL; Poletti G; Visani G; Lemoli RM; Bandini G; Cavo M; Galieni P Haematologica; 1988; 73(6):503-8. PubMed ID: 3148513 [No Abstract] [Full Text] [Related]
20. [Recent experimental researches on Peptichemio]. De Barbieri A G Ital Chemioter; 1974; 21(1):2-4. PubMed ID: 4549578 [No Abstract] [Full Text] [Related] [Next] [New Search]